Actavis, the Iceland-based generic company, on Thursday launched the most high profile commercial challenge in western Europe to Pfizer’s best-selling and patent-protected medicine.

The company said it had made a first shipment of 30m tablets into Spain of a cheaper variant of Lipitor, known generically as atorvastatin, which is widely prescribed by doctors to lower cholesterol in the blood.